better diabetes outcomes
start at hospital discharge
>1 hour increase in time
in range for T1D and
T2D after 12 weeks
1,2
>1% A1C reduction
after 12 weeks
1,2,5
Features to reduce
rebound hyper- and
hypoglycemia
6-8
Dexcom G7 is clinically proven to improve glycemic outcomes
1-5
35%
(~$358 PPPM)
reduced diabetes-
related inpatient
admission costs
9
~50%
reduced diabetes-
related inpatient
visits
10
Patients using Dexcom
CGM resulted in:
Smart devices sold separately. For a list of compatible
devices, visit dexcom.com/compatibility.
PPPM = per patient per month; T1D = type 1 diabetes; T2D = type 2 diabetes.
BRIEF SAFETY STATEMENT: Failure to use the Dexcom G7 Continuous Glucose Monitoring System (G7) and its components according to the instructions for use
provided with your device and available at https://www.dexcom.com/safety-information and to properly consider all indications, contraindications, warnings,
precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose)
occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the G7 do not match symptoms, use a blood
glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency.
1 Beck RW, et al. JAMA. 2017;317(4):371-378. 2 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374. 3 Martens T, et al. JAMA. 2021;325(22):2262-2272. 4 Laffel LM, et
al. JAMA. 2020;323(23):2388-2396. 5 Welsh JB, et al. J Diabetes Sci Technol. 2024;18(1):143-147. 6 Dexcom G7 User Guide, 2023. 7 Acciaroli G, et al. J Diabetes Sci
Technol. 2022;16(3):677-682. 8 Wilmot E. Dexcom G7: Unique Features and Correlational Improvements in Glycemic Control. Presented at the 16th International
ATTD Conference on February 23, 2023. 9 Norman GJ, et al. Diabetes Technol Ther. 2022;24(7):520-524. 10 Hannah K,
et al. Diabetes. 2023;72(Suppl 1):991-P.
Dexcom and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc.
in the United States and/or other countries.
©2024 Dexcom, Inc. All rights reserved. MAT-4717
To learn more about the Dexcom hospital
discharge program, scan the QR code
